Be a Smart Investor
Monday, August 28, 2017
Gilead buys Kite for $11.9 billion
CNBC's David Faber peels back the details on the pharm deal which positions Gilead as the leader in cell therapy.
from Mergers and Acquisitions http://ift.tt/2wWcukz
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment